top of page
PUBLICATIONS

​Wettstein DJ. The impact of value-based pricing policies for new medicines on negotiation behaviour and societal outcomes: implications from three economic experiments. Cumulative thesis submitted for the degree of Ph.D. in Health Sciences at the Department of Health Sciences and Medicine, University of Lucerne. (2022). https://doi.org/10.5281/zenodo.6519458

(Wettstein_2022)

 

Wettstein DJ, Boes S. How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence. Health Policy 126(2), 112-121 (2021). https://doi.org/10.1016/j.healthpol.2021.12.007

 

Wettstein DJ, Boes S. The Impact of Reimbursement Negotiations on Cost and Availability of New Pharmaceuticals: Evidence from an Online Experiment. Health Economics Review. 2020;10(1):13. https://doi.org/10.1186/s13561-020-00267-y

​

Wettstein DJ, Boes S: Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept. BMC Health Serv Res 2021, 21(1):234. https://doi.org/10.1186/s12913-021-06231-8

​

Wettstein DJ, Boes S. Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review. Appl Health Econ Health Policy. (accepted version) 2018. Wettstein_Boes_2018
This is a post-peer-review, pre-copyedit version of an article published in Applied Health Economics and Health Policy. The final authenticated version is available online at: https://doi.org/10.1007/s40258-018-0437-z

​

ORCIDiD_icon128x128.png
bottom of page